Use of medications by people with chronic fatigue syndrome and healthy persons: A population-based study of fatiguing illness in Georgia

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages

  Boneva, Roumiana S ^a   Lin, Jin Mann S ^a   Maloney, Elizabeth M ^a   Jones, James F ^a   Reeves, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIMIGRAINE AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HORMONE ANALOG; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEDATIVE AGENT; THYROID HORMONE; DRUG;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INTERVIEW; MALE; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; SUPPLEMENTATION; ADOLESCENT; CLASSIFICATION; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG THERAPY; HEALTH STATUS; MIDDLE AGED; QUESTIONNAIRE; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; DRUG THERAPY; FATIGUE SYNDROME, CHRONIC; FEMALE; GEORGIA; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; YOUNG ADULT;

EID: 69549105891     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-67     Document Type: Article

References (28)

1. Bombardier CH Buchwald D Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use Med Care 1996, 34:924-930 10.1097/00005650-199609000-00005 8792781
2. Jason LA Richman JA Rademaker AW Jordan KM Plioplys AV Taylor R et al A community-based study of chronic fatigue syndrome Archives of Internal Medicine 1999, 159:2129-2137 10.1001/archinte.159.18.2129 10527290
3. Reyes M Nisenbaum R Hoaglin DC Unger ER Emmons C Randall B et al Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas Arch Intern Med 2003, 163:1530-1536 10.1001/archinte.163.13.1530 12860574
4. Whiting P Bagnall AM Sowden AJ Cornell JE Mulrow CD Ramirez G Interventions for the treatment and management of Chronic fatigue Syndrome: A systematic review JAMA 2001, 286:1360-1368 10.1001/ jama.286.11.1360 11560542
5. Jason LA Taylor RR Kennedy CL Song S Johnson D Torres S Chronic fatigue syndrome: Occupation, medical utilization, and subtypes in a community-based sample J Nerv Ment Dis 2000, 188:568-76 10.1097/ 00005053-200009000-00002 11009329
6. Lin JM Brimmer DJ Boneva RS Jones JF Reeves WC Barriers to healthcare utilization in fatiguing illness: A population-based study in Georgia BMC Health Serv Res 2009, 9:13 2651135 19154587 10.1186/1472-6963-9-13
7. Jones JF Nisenbaum R Reeves WC Medication use by persons with chronic fatigue syndrome: Results of a randomized telephone survey in Wichita, Kansas Health Qual Life Outcomes 2003, 1:74 14651754 10.1186/ 1477-7525-1-74 293479
8. Reeves WC Jones JF Maloney E Heim C Hoaglin DC Boneva RS Morrissey M Devlin R Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia Popul Health Metr 2007:5 (doi: 10.1186/1478-7954-5-5.) 1904178 17559660
9. Fukuda K Straus SE Hickie I Sharpe MC Dobbins JG Komaroff A International Chronic Fatigue Syndrome Study Group The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study Ann Intern Med 1994, 121(12):953-959 http://www.annals.org/cgi/content/full/ 121/12/953 7978722
10. Reeves WC Lloyd A Vernon SD Klimas N Jason LA Bleijenberg G Evengard B White PD Nisenbaum R Unger ER International Chronic Fatigue Syndrome Study Group Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution BMC Health Serv Res 2003, 3:25 317472 14702202 10.1186/1472-6963-3-25
11. Zung WW A self-rating depression scale Arch Gen Psychiatry 1965, 12:63-70 14221692
12. Reeves WC Wagner D Nisenbaum R Jones JF Gurbaxani B Solomon L Papanicolaou DA Unger ER Vernon SD Heim C Chronic fatigue syndrome - a clinically empirical approach to its definition and study BMC Med 2005, 3:19 1334212 16356178 10.1186/1741-7015-3-19
13. Ware JE Sherbourne CD The MOS 36-item short form health survey (SF-36): conceptual framework and item selection Med Care 1992, 30:473-483 10.1097/00005650-199206000-00002 1593914
14. Smets EM Garssen B Bonke B De Haes JC The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue J Psychosom Res 1995, 39:315-325 10.1016/0022-3999(94)00125-O 7636775
15. Wagner D Nisenbaum R Heim C Jones JF Unger ER Reeves WC Psychometric properties of a symptom-based questionnaire for the assessment of chronic fatigue-syndrome Popul Health Metr 2005, 3:8 10.1186/ 1478-7954-3-8 16042777 1183246
16. Sloan Survey, University of Boston http://www.bu.edu/slone/SloneSurvey/ AnnualRpt/SloneSurveyWebReport2006.pdf
17. CDC Prevalence of self-reported arthritis or chronic joint symptoms among adults - United States, 2001 MMWR Morb Mortal Wkly Rep 2002, 51(42):948-950 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5142a2.htm 12437034
18. Scheurer ME El-Zein R Thompson PA Aldape KD Levin VA Gilbert MR Weinberg JS Bondy ML Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk Cancer Epidemiol Biomarkers Prev 2008, 17(5):1277-1281 18483351 10.1158/1055-9965.EPI-07-2621
19. Marcotte DE Wilcox-Gök V Redmo DP Prevalence and Patterns of Major Depressive Disorder in the United States Labor Force J Ment Health Policy Econ 1999, 2(3):123-131 11967420 10.1002/ (SICI)1099-176X(199909)2:3<123::AID-MHP55>3.0.CO;2-8
20. Nater UM Lin JM Maloney EM Jones JF Tian H Boneva RS Raison CL Reeves WC Heim C Psychiatric Co-morbidity in Persons with Chronic Fatigue Syndrome Identified from the Georgia Population Psychosom Med 2009, 71(5):557-565 19414619 10.1097/PSY.0b013e31819ea179
21. Fava M Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment J Clin Psychiatry 2003, 64(Suppl 14):30-34 14658933
22. Greco T Eckert G Kroenke K The outcome of physical symptoms with treatment of depression Journal of General Internal Medicine 2004, 19:813-818 1492507 15242465 10.1111/j.1525-1497.2004.30531.x
23. Heim C Wagner D Maloney E Papanicolaou DA Solomon L Jones JF Unger ER Reeves WC Early adverse experience and risk for chronic fatigue syndrome: Results from a population-based study Arch Gen Psychiatry 2006, 63:1258-66 10.1001/archpsyc.63.11.1258 17088506
24. Nemeroff CB Heim CM Thase ME Klein DN Rush AJ Schatzberg AF Ninan PT McCullough JP Jr Weiss PM Dunner DL Rothbaum BO Kornstein S Keitner G Keller MB Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma Proc Natl Acad Sci USA 2003, 100:14293-14296 283585 14615578 10.1073/ pnas.2336126100
25. Furu K Straume B Use of antiacids in a general population: The impact of health-related variables, lifestyle and socio-economic characteristics J Clin Epidemiol 1999, 52:509-516 10.1016/S0895-4356(99)00020-7 10408989
26. Dillon C Paulose-Ram R Hirsch R Gu Q Skeletal muscle relaxant use in the United States: Data from the Third National Health and Nutrition Examination Survey (NHANES III) Spine 2004, 29:892-6 10.1097/ 00007632-200404150-00014 15082991
27. Carvalho AF Cavalcante JL Castelo MS Lima MC Augmentation strategies for treatment-resistant depression: A literature review J Clin Pharm Ther 2007, 32:415-28 10.1111/j.1365-2710.2007.00787.x 17875106
28. Budnitz DS Pollock DA Weidenbach KN Mendelsohn AB Schroeder TJ Annest JL National surveillance of emergency department visits for outpatient adverse drug events JAMA 2006, 296:1858-1866 10.1001/jama.296.15.1858 17047216